Loading clinical trials...
Loading clinical trials...
After gastric bypass, 10-20% of patients will obtain a suboptimal weight loss, often defined as \<50% of the excess body weight. Exaggerated meal related secretion of gut hormones seem important for appetite reduction and subsequent weight loss after gastric bypass, however it is not clear whether different gut hormone responses are responsible for different postoperative weight loss responses. The purpose of the study is to investigate gut hormone secretion, vagal integrity and the effect of octreotide on ad libitum food intake in patients with suboptimal weight loss after gastric bypass and compare results to a matched group of gastric bypass operated patients with high postoperative weight loss but similar age, sex and preoperative BMI.
Age
20 - 75 years
Sex
ALL
Healthy Volunteers
No
Department of Endocrinology, Hvidovre Hospital
Hvidovre, Denmark
Start Date
October 1, 2014
Primary Completion Date
December 1, 2016
Completion Date
June 1, 2017
Last Updated
February 7, 2017
40
ACTUAL participants
Meal tests after saline injection
OTHER
Meal tests after octreotide injection
OTHER
Sham feeding
OTHER
Lead Sponsor
Hvidovre University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions